Yousif Abdelbagi, Talal Asif, and Devin Gloria
Abstract:
New advancements in medical technology are making it possible to treat conditions that were previously difficult or even impossible to manage. Among the most promising of these technologies are nano-drugs specifically engineered to enter the body and target disease at the cellular level. What made nano-drugs so promising was that they often come with minimal side effects. However, because each individual has unique genetic and biological characteristics, a one-size-fits-all approach to nano-drugs is no longer ideal. This calls for a way to tailor these technologies to each and every person who relies on them. Personalized medicine has become
more and more popular over the years, ultimately transforming healthcare. By creating treatment plans using individual patients’ genetic, biological, and lifestyle data, the healthcare system can drastically improve treatment efficiency. This paper explores the potential benefits that come with integrating personalized medicine with nano-drug technologies. Additionally, our focus is not just on the healthcare benefits, as we dive into how this works from a business standpoint. Using
research from recent literature in biomedical engineering and healthcare marketing, we examine just how nano-drugs work to treat patients while also discussing the potential economic and ethical implications. This paper also focuses on the challenges of implementing this sort of system into healthcare, such as cost, accessibility, and data/privacy concerns. Overall, this paper dives into the possibilities of personalized nano-drug treatment for both patients and the healthcare system, while tracking the risks that come along with it.